Compare Global X Defense Tech ETF (SHLD) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X Defense Tech ETF vs TransMedics Group Inc — how do they compare? Global X Defense Tech ETF trades at $59.87 (market cap $6.29B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: Global X Defense Tech ETF is far larger — about 2.3× TransMedics Group Inc's market cap, and TransMedics Group Inc is more actively traded (949,331 versus 1,133,252). Which is the better fit depends on your goals — on Pluang, investors hold Global X Defense Tech ETF for 44 Days and TransMedics Group Inc for 24 Days on average.
| SHLD | TMDX | |
|---|---|---|
Market Cap | $6.29B | $2.74B |
Volume | 1,133,252 | 949,331 |
Sector | Sector/Thematic | Health |
52-Week High | $78.02 | $150.42 |
52-Week Low | $58.20 | $61.99 |
Typical Hold Time | 44 Days | 24 Days |
Enterprise Value | — | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SHLD (Global X Defense Tech ETF) trades at $59.19, up 0.77% today, but technical indicators show a bearish trend with moving averages signaling strong selling pressure. The ETF focuses on defense technology companies, benefiting from increased global defense spending and institutional accumulation. Recent news highlights growing investor interest as European allies push for rearmament, creating potential tailwinds for defense-focused portfolios.
The outlook remains cautiously optimistic given rising defense budgets and geopolitical tensions, though the bearish technical picture suggests near-term volatility. Investment opportunities center on exposure to cutting-edge defense innovation, while risks include political uncertainty and execution challenges in defense procurement cycles.
TransMedics Group (TMDX) trades at $79.00, down 2.55% amid bearish technical signals and mixed earnings performance. The stock shows strong fundamentals with 58.69% gross margins and 22.69% net income margins, though profitability declined year-over-year. Recent news highlights insider buying, CFO appointment, and ongoing legal investigations into fiduciary duties, creating conflicting sentiment signals.
While analyst consensus remains bullish with a $99.75 price target, near-term risks include margin pressure from heavy investments and legal uncertainties. The stock's current valuation at 20.47 P/E offers potential upside if execution improves, but investors face volatility from earnings misses and regulatory scrutiny.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Global X Defense Tech ETF
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
